Editorial
  Lung cancer in Singapore
   
  Lead Stories
  Mechanistic insights into lung cancer
   
  Lung cancer chemoprevention - why does it not work?
   
  Does radiological screening help in lung cancer?
   
  Non-small cell lung cancer: emerging therapies
   
  From NCC Tumour Board Files
   
  NCC Roundup
   
  Onco Quiz
   
  Lung cancer: an overview
   
  Pharmarcy Tips
  Smoking cessation products
   
  Staff Directory
   
  Contact
   

 

 

Top

 

Lung cancer in Singapore
 
In Singapore, overall mortality has declined from 5.2 per 1,000 in 1972 to 4.5 per 1,000 in 1995. Nevertheless, cancer-related deaths have increased from 14.8% between 1968 to 1972, to 25.6% currently. Overwhelming presence of lung cancer contributes to this increase. It is the leading cause of cancer deaths in males with ASR (Age Standardized rate per 100,000 per year) of 43.0, and the third leading cancer but leading cause of cancer death in females at ASR of 16.0 (1993 to 1997 figures).

Grim mortality figures underlined the need for new approaches. There is a need to reduce factors, take chemoprevention measures, adopt early diagnostic strategies and improve treatment by having a better understanding of the pathogenesis. Epidemiological studies have shown that most lung cancer cases are attributable to smoking. Only 5 % to 10% of lung cancers occur in patients with no prior history of smoking. Compared with non-smokers, smokers have a 10-fold greater risk of dying from lung cancer and in heavy smokers, this risk increases to 15-25-fold. As such, smoking cessation is important in lung cancer prevention and in Pharmacy Tips, some pharmaceutical interventions are presented.

Cancer can be treated curatively with surgery in the early stage cancer. Recent developments in scanning technologies have made early diagnostic screening a reality. Over 80% of lung cancers are attributed to tobacco, yet only some smokers develop lung cancer. Inheritance-pattern studies suggest that a small number of lung cancer cases are a result of lung cancer genes that are likely to be of low frequency, but high in penetration. Multiple genetically determined factors might abrogate the effects of environmental carcinogens and thus explain differences in susceptibility.

In this day and age of genomics and proteomics, we are beginning to understand the origin of this cancer and improve preventive and treatment strategies. So read on and take with us a ‘zooming trip’ for an overview of management lung cancer management and some state- of-the-art, multi-disciplinary management approaches.

Dr Sandeep Rajan
Editor